Please wait
S-3 424B5 EX-FILING FEES 333-279299 0001710072 Edgewise Therapeutics, Inc. The prospectus is not a final prospectus for the related offering. 0001710072 2025-04-02 2025-04-02 0001710072 1 2025-04-02 2025-04-02 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Edgewise Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, $0.0001 par value per share 457(r) 9,935,419 $ 20.13 $ 199,999,984.47 0.0001531 $ 30,620.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 199,999,984.47

$ 30,620.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 30,620.00

Offering Note

1

Payment of the registration fee at the time of filing of the registrant's Registration Statement on Form S-3ASR (File No. 333-279299) on May 10, 2024 (the "Registration Statement") was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act of 1933, as amended and is paid herewith. This "Calculation of Filing Fee" table shall be deemed to update the table in Item 14 of the Registration Statement on Form S-3.